Influence of Sex, Gender, and Sociodemographic Variables on Recurrent Prescription Refills for Chronic Pain: Findings from a Prescription Claims Analysis - Takeaways - MDSpire

Influence of Sex, Gender, and Sociodemographic Variables on Recurrent Prescription Refills for Chronic Pain: Findings from a Prescription Claims Analysis

  • By

  • Marimée Godbout-Parent

  • Nancy Julien

  • Hermine Lore Nguena Nguefack

  • M. Gabrielle Pagé

  • Line Guénette

  • Lucie Blais

  • Nancy Ménard

  • Sylvie Beaudoin

  • Anaïs Lacasse

  • April 22, 2026

  • 0 min

Share

  • 1

    Chronic pain disproportionately affects women and gender-diverse individuals, necessitating an equity-oriented approach to care.

  • 2

    The study analyzed prescription refills for pain medications among 561 individuals with chronic pain, linking self-reported data to prescription claims.

  • 3

    Antidepressants (48%) and anticonvulsants (35%) were the most commonly refilled medications for chronic pain in the study.

  • 4

    Statistically significant differences in prescription refills were found among sociodemographic subgroups, particularly for opioids and antidepressants.

  • 5

    The findings underscore the importance of considering sex, gender, and sociodemographic factors in optimizing chronic pain medication management.

Original Source(s)

Influence of Sex, Gender, and Sociodemographic Variables on Recurrent Prescription Refills for Chronic Pain: Findings from a Prescription Claims Analysis

  • by Marimée Godbout-Parent, Nancy Julien, Hermine Lore Nguena Nguefack, M. Gabrielle Pagé, Line Guénette, Lucie Blais, Nancy Ménard, Sylvie Beaudoin, Anaïs Lacasse

  • April 22, 2026

Related Content

Urgent Care, Unchecked Power

An unsupervised clinic model and blurred boundaries expose how oversight can fail in outpatient care.

Observing and treating pain in people living with dementia in long-term care facilities

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.